Queen Elizabeth Hospital in King’s Lynn, England has partnered with Inivos, an infection prevention and control company, to introduce a clinical ultraviolet-C (UV-C) technology in response to the ongoing Covid-19 pandemic.

Inivos’ UV-C technology is designed to decontaminate healthcare spaces of pathogenic microorganisms such as Clostridium difficile, Staphylococcus aureus and SARS-CoV-2, the novel coronavirus that causes Covid-19.

The technology is said to use UV-C light produced by ten UV-C lamps to decontaminate a space in just ten minutes, helping the hospital deep clean patient areas quicker.

It is calibrated with specialist monitoring technology called spectromes, six of which are placed in various areas of the room to constantly track the UV level being transmitted throughout the process.

Each spectrome transmits captured data to a central tablet that provides auto-generated reports in real-time. These reports can be reviewed by hospital staff to check the status of a cycle and if the space is safe to inhabit.

Queen Elizabeth Hospital chief nurse, said: “We are so grateful to Inivos for supplying this incredible piece of kit to the QEH. Working with this innovative equipment will support our domestic services teams to deep clean patient areas quicker, in turn allowing us to care for more patients.

“We are looking forward to developing our relationship with Inivos and hopefully launch some research and development projects with them in the future.”

The hospital’s domestic service manager added that the technology will help improve the deep cleaning process and decrease the risk of infection.